D-1388-2019 Class II Terminated
FDA drug recall D-1388-2019 was initiated by Sun Pharmaceutical Industries, Inc. on Jun 5, 2019 and is designated Class II. Reason for recall: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit The recall status is terminated (terminated Jan 8, 2021). Affected quantity: 17,136 20-count units.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2019
- Initiation Date
- Jun 5, 2019
- Termination Date
- Jan 8, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,136 20-count units
Product description
Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 20-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 43023 1
Reason for recall
Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Distribution pattern
Nationwide in the USA
Code information
Lot GKT0791, EXP 06/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1388-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026